Synjardy

Active Ingredient(s): Empagliflozin + Metformin Hydrochloride
FDA Approved: * August 26, 2015
Pharm Company: * BOEHRINGER INGELHEIM
Category: Diabetes

Empagliflozin, sold under the brand name Jardiance among others, is an antidiabetic medication used to improve glucose control in people with type 2 diabetes, used to reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease, used to reduce the risk of death and hospitalization in people with heart failure and low ejection fraction, and used to reduce the risk of cardiovascular death and hospitalization for heart failure in adults.[5... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Synjardy Oral Tablet
NDC: 0597-0159
Labeler:
Boehringer Ingelheim Pharmaceuticals, Inc.
Synjardy Oral Tablet
NDC: 0597-0168
Labeler:
Boehringer Ingelheim Pharmaceuticals, Inc.
Synjardy Oral Tablet
NDC: 0597-0175
Labeler:
Boehringer Ingelheim Pharmaceuticals, Inc.
Synjardy Oral Tablet
NDC: 0597-0180
Labeler:
Boehringer Ingelheim Pharmaceuticals, Inc.

Related Brands

Drugs with the same active ingredients